Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized, Controlled, Non-inferiority Clinical Trial to Evaluate the Safety and Efficacy of LineMatrix® Biological Vascular Graft for the Creation of Arteriovenous Graft

NCT07773051 is registered in ClinicalTrials.gov with Longhua Hospital as lead sponsor.

NCT NCT07773051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07773051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized, Controlled, Non-inferiority Clinical Trial to Evaluate the Safety and Efficacy of LineMatrix® Biological Vascular Graft for the Creation of Arteriovenous Graft
Lead sponsor
Longhua Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
August 25, 2025
Completion date
September 30, 2027
Enrollment
326 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

arteriovenous graft